Every day, America’s hospitals and health systems are on the front lines of combatting the epidemic of addiction to prescription opioids or heroin. This public health crisis is rapidly growing in communities across the country and can no longer be ignored. To that end, the Administration announced this week as Prescription Opioid and Heroin Epidemic Awareness Week.  To help patients, hospitals and communities combat the opioid epidemic, the AHA has a variety of resources to help, including: 

  • Webinars
  • Information on advocacy efforts
  • Case examples

The AHA also worked with the CDC to develop a special patient-friendly fact sheet about the use of prescription opioids.  While prescription opioids can be a safe and necessary part of pain management, these drugs also carry serious risks of harm because of the potential for addiction, misuse, overdose and death. We encourage physicians and patients to use the fact sheet to talk about the best ways to manage pain and the potential risks and benefits of using prescription opioids. 

 Prescription Opioids: What You Need to Know

The AHA will continue to share resources and tools that help everyone – hospitals, providers, patients and communities – address the epidemic of addiction to prescription opioids or heroin. 

Related News Articles

Federal agencies last month stopped over 500 unapproved pharmaceutical products and medical devices, including opioid and other controlled substances, from…
As the House Energy and Commerce Committee works to reauthorize key programs within the Substance Use-Disorder Prevention that Promotes Opioid Recovery and…
While counseling and other services are an important part of a comprehensive treatment plan for opioid use disorder, the provision of medication should not be…
AHA today launched an updated Opioid Stewardship Hub, featuring the latest tools and resources to help hospitals and health systems address the opioid epidemic…
The Food and Drug Administration last week required certain labeling updates for opioid pain medicines in an effort to reduce unnecessary prescribing and…
The Food and Drug Administration April 3 announced that it will require manufacturers of opioid analgesics used in outpatient settings to modify their Risk…